The efficiency of monotherapy of patients with primary open-angle glaucoma with Bimatoprost 0.03 % (Bimoptic)
Purpose: to evaluate the hypotensive effect and adverse reactions occurrence in patients with primary open angle glaucoma (POAG) who received Bimatoprost (Bimoptic Rompharm) monotherapy.Materials and methods. 46 patients (75 eyes) with stage I–III POAG were prescribed bimatoprost therapy. Of these,...
Main Authors: | S. A. Korotkikh, G. V. Zhiborkin, E. S. Knyazeva, L. V. Rusakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Real Time Ltd
2018-12-01
|
Series: | Российский офтальмологический журнал |
Subjects: | |
Online Access: | https://roj.igb.ru/jour/article/view/197 |
Similar Items
-
Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% – an observational switch study
by: Deshpande SS, et al.
Published: (2017-07-01) -
Efficacy of Monotherapy with Either Bimatoprost or Travoprost in Patients with Primary Open-Angle Glaucoma Resistant to Latanoprost Therapy
by: Yusuf Koçluk, et al.
Published: (2011-10-01) -
Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: A preliminary study
by: Vyas Prateep, et al.
Published: (2011-01-01) -
Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice
by: Pfennigsdorf S, et al.
Published: (2016-09-01) -
Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
by: Pillunat LE, et al.
Published: (2016-09-01)